Main criteria and risk factors for the development of recurrent endometriosis


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective: To analyze the data available in the current literature on the recurrence of different forms of endometriosis and to identify the main criteria and risk factors for the development of a relapse of the disease. The review article includes the data published by foreign and Russian authors in the Pubmed, UpToDate, and eLibrary databases on the keywords "endometriosis", " deep infiltrating endometriosis", and "recurrent endometriosis". Endometriosis is observed in 10% of reproductive-aged women and ranks third among gynecological diseases. The literature review focuses on risk factors for recurrent endometriosis. The term “recurrent endometriosis” is non-uniform and ambiguous; different studies describe various parameters of recurrent disease. This concept is used in different sources of literature in different ways: as recurrent pain, as the detection of new lesions by pelvic ultrasound or MRI, as a repeated increase in CA-125 levels, or as a surgical finding of new endometrioid implants during surgery unassociated with endometriosis. Conclusion: At the moment, there are no unified clinical and molecular criteria for recurrent endometriosis. The lack of understanding of risk factors for recurrent endometriosis cannot build a unified strategy for early diagnosis, timely therapy and surgical treatment

Texto integral

Acesso é fechado

Sobre autores

Daria Senina

I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia; Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: seninadashal995@gmail.com
PhD student, Surgical Department

Vladimir Chuprynin

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: v_chuprynin@oparina4.ru
PhD, Head of the Surgical Department

Natalya Buralkina

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: ralkina@yandex.ru
Dr. Med. Sci., Senior Researcher at Surgical Department

Vyacheslav Chursin

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: v_chursin@oparina4.ru
surgeon at the Department of General Surgery

Tatyana Smolnova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: smoltat@list.ru
Dr. Med. Sci., Senior Reseacher at the Surgery Department

Liana Davidyan

Ulyanovsk State University

Email: dliana2009@mail.ru
Dr. Med. Sci., Professor of the Faculty of postgraduate medical and pharmaceutical education

Azizbek Abosov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: abosovazizbekll@gmail.com
resident

Bibliografia

  1. Schenken R.S., Barbieri R.L., Eckler K. Endometriosis: pathogenesis, clinical features, and diagnosis. UpToDate; 2019.
  2. Dunselman G.A., Vermeulen N., Becker C., Calhaz-Jorge C., D'Hooghe T., De Bie B. et al.; European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum. Reprod. 2014; 29(3): 400-12. https://dx.doi.org/10.1093/humrep/det457.
  3. Nisolle M., Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil. Steril. 1997; 68(4): 585-96. https://dx.doi.org/10.1016/s0015-0282(97)00191-x.
  4. Smolarz B., Szyllo K., Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (Review of Literature). Int. J. Mol. Sci. 2022; 22(19): 10554. https://dx.doi.org/10.3390/ijms221910554.
  5. Donnez J., Pirard C., Smets M., Jadoul P., Squifflet J. Surgical management of endometriosis. Best Pract. Res. Clin. Obstet. Gynaecol. 2004; 18(2): 329-48. https://dx.doi.org/10.1016/j.bpobgyn.2014.03.004.
  6. Guo S.-W., Martin D.C. The perioperative period: a critical yet neglected time window for reducing the recurrence risk of endometriosis? Hum. Reprod. 2019; 34(10): 1858-65. https://dx.doi.org/10.1093/humrep/dez187.
  7. Guo S.-W. Recurrence of endometriosis and its control. Hum. Reprod. Update. 2009; 15(4): 441-61. https://dx.doi.org/10.1093/humupd/dmp007.
  8. Lee D.Y., Lee J.Y., Seo J.W., Yoon B.K., Choi D. Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis. Arch. Gynecol. Obstet. 2016; 294(6): 1257-63. https://dx.doi.org/10.1007/s00404-016-4184-9.
  9. Yang F., Liu B., Xu L., Liu H. Age at surgery and recurrence of ovarian endometrioma after conservative surgery: a meta-analysis including 3125 patients. Arch. Gynecol. Obstet. 2020; 302(1): 23-30. https://dx.doi.org/10.1007/s00404-020-05586-3.
  10. Parazzini F., Bertulessi C., Pasini A., Rosati M., Di Stefano F., Shonauer S. et al. Determinants of short term recurrence rate of endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2015; 121(2): 16-9. https://dx.doi.org/10.1016/j.ejogrb.2004.11.033.
  11. Zakhari A., Delpero E., McKeown S., Tomlinson G., Bougie O., Murji A. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum. Reprod. Update. 2021; 27(1): 96-107. https://dx.doi.org/10.1093.
  12. Saleh A., Tulandi T. Reoperation after laparoscopic treatment of ovarian endometriomas by excision and by fenestration. Ferti.l Steril. 1999; 72(2): 322-4. https://dx.doi.org/10.1016/s0015-0282(99)00243-5.
  13. Porpora M.G., Pallante D., Ferro A., Crisafi B., Bellati F., Benedetti Panici P. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil. Steril. 2010; 93(3): 716-21. https://dx.doi.org/10.1016/j.fertnstert.2008.10.018.
  14. Nowak-Psiorz.I., Ciecwiez S.M., Brodowska A., Starczewski A. Treatment of ovarian endometrial cysts in the context of recurrence and fertility. Adv. Clin. Exp. Med. 2019; 28(3): 407-13. https://dx.doi.ois/10.17219/acem/90767.
  15. Ершова И.Ю., Краснопольская К.В., Попов А.А., Краснопольская И.В., Коваль А.А. Состояние овариального резерва у пациенток с бесплодием после операций по поводу двусторонних эндометриоидных кист яичников. Проблемы репродукции. 2021; 27(4): 56-63.
  16. Chen I., Veth V.B., Choudhry A.J., Murji A., Zakhari A., Black A.Y. et al. Preand postsurgical medical therapy for endometriosis surgery. Cochrane Database Syst. Rev. 2020; 11(11): CD003678. https://dx.doi.org/10.1002/14651858.CD003678.pub3.
  17. Leeners B., Damaso F., Ochsenbein-Kolble N., Farquhar C. The effect of pregnancy on endometriosis-facts or fiction? Hum. Reprod. Update. 2018; 24(3): 290-9. https://dx.doi.org/10.1093/humupd/dmy004.
  18. Джобава Э.М., Мандрыкина Ж.А., Логинова К.Б., Доброхотова Ю.Э. Дисменорея. Этиопатогенез, дифференциальная диагностика и терапия в практике современного акушера-гинеколога. РМЖ. Мать и дитя. 2012; 20(1): 28-34.
  19. Scioscia M., Bruni F., Ceccaroni M., Steinkasserer M., Stepniewska A., Minelli L. Distribution of endometriotic lesions in endometriosis stage IV supports the menstrual reflux theory and requires specific preoperative assessment and therapy. Acta Obstet. Gynecol. Scand. 2011; 90(2): 136-9. https://dx.doi.org/10.1111/j.1600-0412.2010.01008.x.21.
  20. Matorras R., Elorriaga M.A., Pijoan J.I., Ramo’n O., Rodriguez Escudero F.J. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil. Steril. 2012; 77(2): 303-8. https://dx.doi.org/10.1016/s0015-0282(01)02981-8.
  21. Адамян Л.B., Арсланян КН., Харченко Э.И., Логинова О.Н. Современные направления в медикаментозном лечении эндометриоза. Проблемы репродукции. 2019; 25(6): 58-66. https://dx.doi.org/10.17116/repro20192506158.
  22. Муфтайдинова Ш.К., Файзуллин Л.З., Чупрынин В.Д., Русейкин НС., Смольнова Т.Ю., Буралкина Н.А. Клинико-диагностические аспекты глубокого инфильтративного эндометриоза (диагностика, лечение, рецидивы). Гинекология. 2021; 23(4): 307-13.
  23. Maillard C.,Cherif Alami Z., Squifflet J.L.,Luyckx M., Jadoul P., Thomas V.,Wyns C. Diagnosis and treatment of vulvo-perineal endometriosis: a systematic review. Front. Surg. 2021; 8: 637180. https://dx.doi.org,/10.3389/fsurg.2021.637180.
  24. Biacchiardi C.P., Piane L.D., Cam ami М., Deltetto E., Delpiano E.M., Marchino G.L. et al. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod. Biomed. Online. 2011; 23(6): 740-6. https://dx.doi.org/10.1016/j.rbmo.2011.07.014.
  25. Busacca М., Chiqffdrino E., Candiani М., Vignali М., Bertulessi C., Oggioni G., Parazzini F. Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis. Am. J. Obstet. Gynecol. 2016; 195(2): 426-32. https://dx.doi.Org/10.1016/j.ajog.2006.01.078.
  26. Nezhat C., Hajhosseini B., King L.P. Laparoscopic management of bowel endometriosis: predictors of severe disease and recurrence. JSLS. 2011; 15(4): 431-8. https://dx.doi.org/10.4293/108680811X13176785203752.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2022